Impact of Anti-TNF&#945; Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.

Tursi, Antonio; Papa, Alfredo

Impact of Anti-TNFα Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.

Tursi, Antonio; Papa, Alfredo.

Tursi A; Territorial Gastroenterology Service, ASL BAT, Andria (BT), Italy.
Papa A; Division of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.

J Crohns Colitis ; 14(11): 1646-1647, 2020 Nov 07.

Article in English | MEDLINE | ID: covidwho-1003552

Subject(s)

Adalimumab/adverse effects; Anti-Inflammatory Agents/adverse effects; Betacoronavirus; Coronavirus Infections/immunology; Crohn Disease/drug therapy; Immunocompromised Host; Pneumonia, Viral/immunology; Adalimumab/therapeutic use; Adult; Anti-Inflammatory Agents/therapeutic use; COVID-19; Coronavirus Infections/diagnosis; Crohn Disease/complications; Crohn Disease/immunology; Humans; Male; Pandemics; Pneumonia, Viral/diagnosis; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Crohn Disease / Immunocompromised Host / Coronavirus Infections / Adalimumab / Betacoronavirus / Anti-Inflammatory Agents Type of study: Case report / Diagnostic study / Experimental Studies / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Language: English Journal: J Crohns Colitis Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: Ecco-jcc

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google